PA
PAYO icon

PharVision Advisers’s Payoneer PAYO Stock Holding History

PharVision Advisers’s Portfolio PAYO Stock Details PAYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-54,830
Closed -$332K – 925
2025
Q3 		$332K Buy
+54,830
New +$367K 0.19% 169
2025
Q1 		– Sell
-12,439
Closed -$125K – 457
2024
Q4 		$125K Buy
+12,439
New +$119K 0.11% 362

Other funds holding PAYO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMV
Technology Crossover Management VIII Menlo Park, California $298M AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Susquehanna Capital Management Bala Cynwyd, Pennsylvania $99.2M AUM 33.93% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's PAYO Position: Q4 2025 in Review

PharVision Advisers sold out of Payoneer (PAYO) in Q4 2025, closing a stake of 54,830 shares — an estimated $332K sold.

PharVision Advisers first reported a position in PAYO in Q4 2024 and held it in 2 quarters. The position peaked at $332K in Q3 2025. 287 funds tracked by Wall St. Rank hold PAYO as of Q4 2025.

  • PharVision Advisers reported no remaining Payoneer position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 54,830 Payoneer shares in Q4 2025, an estimated $332K.
  • PharVision Advisers first reported a position in Payoneer in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Payoneer position peaked at $332K in Q3 2025.
  • 287 funds tracked by Wall St. Rank held Payoneer as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.